Technical Analysis for LIFE - aTyr Pharma, Inc.

Grade Last Price % Change Price Change
grade B 5.38 2.87% 0.15
LIFE closed up 2.87 percent on Wednesday, July 17, 2019, on 57 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical LIFE trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
NR7 Range Contraction 2.87%
Inside Day Range Contraction 2.87%
Wide Bands Range Expansion 2.87%
Overbought Stochastic Strength 2.87%
Shooting Star Candlestick Bearish 3.00%
Pocket Pivot Bullish Swing Setup 3.00%
New 52 Week High Strength 3.00%

Older signals for LIFE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
Organ Systems Muscular Dystrophy Dystrophy Myopathy Severe And Rare Diseases
Is LIFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.97
52 Week Low 0.3101
Average Volume 390,907
200-Day Moving Average 0.8072
50-Day Moving Average 1.5521
20-Day Moving Average 3.218
10-Day Moving Average 5.0493
Average True Range 0.4936
ADX 47.72
+DI 51.745
-DI 13.2391
Chandelier Exit (Long, 3 ATRs ) 4.4892
Chandelier Exit (Short, 3 ATRs ) 1.7909
Upper Bollinger Band 7.8774
Lower Bollinger Band -1.4414
Percent B (%b) 0.73
BandWidth 289.583592
MACD Line 1.2463
MACD Signal Line 1.1142
MACD Histogram 0.132
Fundamentals Value
Market Cap 128.25 Million
Num Shares 23.8 Million
EPS -2.19
Price-to-Earnings (P/E) Ratio -2.46
Price-to-Sales 0.00
Price-to-Book 2.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.91
Resistance 3 (R3) 5.90 5.73 5.82
Resistance 2 (R2) 5.73 5.59 5.73 5.79
Resistance 1 (R1) 5.55 5.51 5.64 5.56 5.76
Pivot Point 5.38 5.38 5.42 5.38 5.38
Support 1 (S1) 5.20 5.24 5.29 5.21 5.00
Support 2 (S2) 5.03 5.16 5.03 4.97
Support 3 (S3) 4.85 5.03 4.94
Support 4 (S4) 4.86